Guardian Pharmacy Services (NYSE:GRDN) Issues Earnings Results

Guardian Pharmacy Services (NYSE:GRDN) released its earnings results on Thursday. The company reported $0.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.31 by $0.02, FiscalAI reports. Guardian Pharmacy Services had a return on equity of 29.97% and a net margin of 4.50%. The firm had revenue of $371.07 million during the quarter, compared to analysts’ expectations of $365.76 million.

Here are the key takeaways from Guardian Pharmacy Services’ conference call:

• Guardian raised 2026 guidance to revenue of $1.44 billion–$1.46 billion and Adjusted EBITDA of $136 million–$138 million. Third-quarter Adjusted EBITDA rose 24% year over year to $33.9 million, while net income nearly doubled to $19 million.
• Reported revenue fell 1.7% to $371 million, primarily due to IRA-related drug price reductions; management said revenue would have grown at a high-single-digit rate without that impact. Prescription volume increased 10% year over year.
• Growth efforts include new pharmacy locations and acquisitions, including Nautilus, whose residents were transitioned to Guardian pharmacies and whose deal is expected to be accretive after onboarding costs. Management said its acquisition pipeline remains active and sees room to expand through both acquisitions and greenfield openings.
• Management cited improving assisted-living occupancy, complex resident care needs, and Guardian’s estimated 14% share of its primary market as support for continued growth. It said service quality and facility wins—not occupancy alone—are central to expanding the business.
• Guardian is working with payers on reimbursement that better reflects its services and generic-drug mix, which management believes could improve the business’s long-term stability. The company ended the quarter with about $120 million in cash and no debt.

Guardian Pharmacy Services Trading Up 6.5%

Shares of NYSE:GRDN traded up $2.58 during mid-day trading on Friday, reaching $42.45. The company had a trading volume of 1,085,464 shares, compared to its average volume of 383,960. Guardian Pharmacy Services has a one year low of $26.34 and a one year high of $48.33. The company’s 50-day moving average price is $41.42 and its 200-day moving average price is $38.30. The firm has a market cap of $2.11 billion, a price-to-earnings ratio of 36.28, a PEG ratio of 2.09 and a beta of 0.06.

Wall Street Analyst Weigh In

GRDN has been the topic of a number of recent research reports. Weiss Ratings lowered Guardian Pharmacy Services from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, October 23rd. Truist Financial raised their price objective on Guardian Pharmacy Services from $47.00 to $51.00 and gave the company a “buy” rating in a research note on Monday, September 21st. Wall Street Zen lowered Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a report on Sunday, October 25th. KeyCorp began coverage on Guardian Pharmacy Services in a report on Tuesday, September 22nd. They set an “overweight” rating and a $52.00 price target on the stock. Finally, Oppenheimer boosted their price objective on Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an “outperform” rating in a research report on Friday, August 7th. Nine investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $45.57.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc is a provider of pharmacy services focused primarily on residents of long-term care and other institutional healthcare settings. Through its network of pharmacies, the company supplies prescription medications and related pharmacy support to assisted living communities, skilled nursing facilities, behavioral health organizations, and other care providers.

The company’s services include medication dispensing and packaging, prescription delivery, medication management, clinical pharmacy support, and technology-enabled tools designed to help caregivers and healthcare professionals manage residents’ medication regimens.